Bohnen NI - Search Results

1

Decreased striatal monoaminergic terminals in Huntington disease.

Bohnen NI, Koeppe RA, Meyer P, Ficaro E, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Bohnen NI, et al. Neurology. 2000 May 9;54(9):1753-9. doi: 10.1212/wnl.54.9.1753. Neurology. 2000. PMID: 10802780

2

Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia.

Bohnen NI, Minoshima S, Giordani B, Frey KA, Kuhl DE. Bohnen NI, et al. Neurology. 1999 Feb;52(3):541-6. doi: 10.1212/wnl.52.3.541. Neurology. 1999. PMID: 10025784

3

Somatostatin receptor scintigraphy of a patient with a giant invasive prolactinoma.

Meyer P, Bohnen NI, Barkan AL, Shapiro B. Meyer P, et al. Among authors: bohnen ni. Nuklearmedizin. 1999;38(2):66-7. Nuklearmedizin. 1999. PMID: 10100234

4

(+)-alpha-[11C]Dihydrotetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis.

Bohnen NI, Albin RL, Frey KA, Fink JK. Bohnen NI, et al. Neurology. 1999 Mar 23;52(5):1067-9. doi: 10.1212/wnl.52.5.1067. Neurology. 1999. PMID: 10102431

5

Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome.

Meyer P, Bohnen NI, Minoshima S, Koeppe RA, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Meyer P, et al. Among authors: bohnen ni. Neurology. 1999 Jul 22;53(2):371-4. doi: 10.1212/wnl.53.2.371. Neurology. 1999. PMID: 10430428

6

Increased ventral striatal monoaminergic innervation in Tourette syndrome.

Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA. Albin RL, et al. Among authors: bohnen ni. Neurology. 2003 Aug 12;61(3):310-5. doi: 10.1212/01.wnl.0000076181.39162.fc. Neurology. 2003. PMID: 12913189

7

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study.

Bohnen NI, Kaufer DI, Ivanco LS, Lopresti B, Koeppe RA, Davis JG, Mathis CA, Moore RY, DeKosky ST. Bohnen NI, et al. Arch Neurol. 2003 Dec;60(12):1745-8. doi: 10.1001/archneur.60.12.1745. Arch Neurol. 2003. PMID: 14676050

8

The role of positron emission tomography imaging in movement disorders.

Bohnen NI, Frey KA. Bohnen NI, et al. Neuroimaging Clin N Am. 2003 Nov;13(4):791-803. doi: 10.1016/s1052-5149(03)00096-0. Neuroimaging Clin N Am. 2003. PMID: 15024962 Review.

9

Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.

Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Koeppe RA, Meltzer CC, Constantine G, Davis JG, Mathis CA, Dekosky ST, Moore RY. Bohnen NI, et al. J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):315-9. doi: 10.1136/jnnp.2004.038729. J Neurol Neurosurg Psychiatry. 2005. PMID: 15716518 Free PMC article. Clinical Trial.

10

Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.

Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, Frey KA. Bohnen NI, et al. J Cereb Blood Flow Metab. 2006 Sep;26(9):1198-212. doi: 10.1038/sj.jcbfm.9600276. Epub 2006 Jan 18. J Cereb Blood Flow Metab. 2006. PMID: 16421508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters